The clinical impact of additional late PET/CT-imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of recurrent prostate cancer

被引:0
|
作者
Afshar-Oromieh, A. [1 ]
Sattler, L. [1 ]
Kratochwil, C. [1 ]
Giesel, F. [1 ]
Kopka, K. [2 ]
Haberkorn, U. [1 ]
机构
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP552
引用
收藏
页码:S166 / S166
页数:1
相关论文
共 50 条
  • [1] The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer
    Afshar-Oromieh, Ali
    Sattler, Lars Peter
    Mier, Walter
    Hadaschik, Boris A.
    Debus, Juergen
    Holland-Letz, Tim
    Kopka, Klaus
    Haberkorn, Uwe
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 750 - 755
  • [2] Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    Ali Afshar-Oromieh
    Tim Holland-Letz
    Frederik L. Giesel
    Clemens Kratochwil
    Walter Mier
    Sabine Haufe
    Nils Debus
    Matthias Eder
    Michael Eisenhut
    Martin Schäfer
    Oliver Neels
    Markus Hohenfellner
    Klaus Kopka
    Hans-Ulrich Kauczor
    Jürgen Debus
    Uwe Haberkorn
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1258 - 1268
  • [3] Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    Afshar-Oromieh, Ali
    Holland-Letz, Tim
    Giesel, Frederik L.
    Kratochwil, Clemens
    Mier, Walter
    Haufe, Sabine
    Debus, Nils
    Eder, Matthias
    Eisenhut, Michael
    Schaefer, Martin
    Neels, Oliver
    Hohenfellner, Markus
    Kopka, Klaus
    Kauczor, Hans-Ulrich
    Debus, Juergen
    Haberkorn, Uwe
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (08) : 1258 - 1268
  • [4] Erratum to: Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    Ali Afshar-Oromieh
    Tim Holland-Letz
    Frederik L. Giesel
    Clemens Kratochwil
    Walter Mier
    Sabine Haufe
    Nils Debus
    Matthias Eder
    Michael Eisenhut
    Martin Schäfer
    Oliver Neels
    Markus Hohenfellner
    Klaus Kopka
    Hans-Ulrich Kauczor
    Jürgen Debus
    Uwe Haberkorn
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1781 - 1781
  • [5] 68Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer
    Elif Neslihan Akdemir
    Murat Tuncel
    Fadıl Akyol
    Cenk Yucel Bilen
    Dilek Ertoy Baydar
    Erdem Karabulut
    Haluk Ozen
    Meltem Caglar
    [J]. World Journal of Urology, 2019, 37 : 813 - 821
  • [6] 68Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer
    Akdemir, Elif Neslihan
    Tuncel, Murat
    Akyol, Fadil
    Bilen, Cenk Yucel
    Baydar, Dilek Ertoy
    Karabulut, Erdem
    Ozen, Haluk
    Caglar, Meltem
    [J]. WORLD JOURNAL OF UROLOGY, 2019, 37 (05) : 813 - 821
  • [7] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    Afshar-Oromieh, Ali
    Avtzi, Eleni
    Giesel, Frederik L.
    Holland-Letz, Tim
    Linhart, Heinz G.
    Eder, Matthias
    Eisenhut, Michael
    Boxler, Silvan
    Hadaschik, Boris A.
    Kratochwil, Clemens
    Weichert, Wilko
    Kopka, Klaus
    Debus, Juergen
    Haberkorn, Uwe
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 197 - 209
  • [8] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    Ali Afshar-Oromieh
    Eleni Avtzi
    Frederik L. Giesel
    Tim Holland-Letz
    Heinz G. Linhart
    Matthias Eder
    Michael Eisenhut
    Silvan Boxler
    Boris A. Hadaschik
    Clemens Kratochwil
    Wilko Weichert
    Klaus Kopka
    Jürgen Debus
    Uwe Haberkorn
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 197 - 209
  • [9] Impact of Ga-68 HBED-CC PSMA PET/CT on therapeutic management of patients with prostate cancer
    Schreiter, Vera
    Schreiter, Nils
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [10] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of prostate cancer
    Akdemir, E.
    Tuncel, M.
    Tuncali, M. C.
    Bilen, C. Y.
    Akyol, F.
    Baydar, D.
    Ozen, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S679 - S679